Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H19N3O4 |
| Molecular Weight | 281.3077 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCNC(=O)C1=CC(=NC=C1)C(=O)NCCOC
InChI
InChIKey=JUCNGMPTCXPMNB-UHFFFAOYSA-N
InChI=1S/C13H19N3O4/c1-19-7-5-15-12(17)10-3-4-14-11(9-10)13(18)16-6-8-20-2/h3-4,9H,5-8H2,1-2H3,(H,15,17)(H,16,18)
Lufironil (HOE 077) is an inhibitor of prolyl 4-hydroxylase. In preclinical studies, it prevented liver fibrosis by inhibiting not only the hydroxylation of proline but also the activation of Ito cells, which are considered the main collagen-producing cells, resulting in reduced expression of procollagen mRNA. Lufironil was being developed for the treatment of chronic liver diseases including alcoholic hepatitis and liver cirrhosis.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. | 1996-04 |
|
| New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis. | 1995 |
|
| Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. | 1991 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
128075-79-6
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
100000082251
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
C97361
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
60788
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
FF-24
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
8MMU177964
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
DTXSID00155802
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106793
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
6715
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY | |||
|
SUB08616MIG
Created by
admin on Mon Mar 31 18:15:35 GMT 2025 , Edited by admin on Mon Mar 31 18:15:35 GMT 2025
|
PRIMARY |
ACTIVE MOIETY